Table 2.

Primary and secondary outcomes comparison in patients with and without metabolic syndrome.

Outcome	Non-MetS (N = 5520)	MetS (N = 7939)	p-value
Primary outcome
MACCE (%)
Event (%)	478 (8.66)	810 (10.20)	0.003
Unadjusted HR [95% CI]	Ref	1.17 [1.05–1.32]	0.005
Adjusted HR [95% CI]	Ref	1.22 [1.08–1.39]	0.002
Secondary outcomes
Coronary artery bypass grafting
Event (%)	50 (0.90)	87 (1.10)	0.280
Unadjusted HR [95% CI]	Ref	1.21 [0.85–1.71]	0.287
Adjusted HR [95% CI]	Ref	1.29 [0.88–1.89]	0.195
Myocardial infarction
Event (%)	165 (2.99)	301 (3.79)	0.012
Unadjusted HR [95% CI]	Ref	1.27 [1.05–1.54]	0.013
Adjusted HR [95% CI]	Ref	1.43 [1.15–1.76]	0.001
Mortality
Event (%)	161 (2.92)	270 (3.40)	0.116
Unadjusted HR [95% CI]	Ref	1.16 [0.96–1.41]	0.126
Adjusted HR [95% CI]	Ref	1.12 [0.89–1.41]	0.340
Stroke
Event (%)	12 (0.22)	18 (0.23)	0.910
Unadjusted HR [95% CI]	Ref	1.05 [0.51–2.18]	0.892
Adjusted HR [95% CI]	Ref	1.07 [0.44–2.58]	0.881
Target lesion revascularization
Event (%)	51 (0.92)	78 (0.98)	0.732
Unadjusted HR [95% CI]	Ref	1.08 [0.76–1.54]	0.672
Adjusted HR [95% CI]	Ref	1.15 [0.77–1.71]	0.489
Target vessel revascularization
Event (%)	39 (0.71)	56 (0.70)	0.994
Unadjusted HR [95% CI]	Ref	0.99 [0.66–1.49]	0.963
Adjusted HR [95% CI]	Ref	0.84 [0.52–1.34]	0.455

MACCE: major adverse cardiac and cerebrovascular events, HR: hazard ratio, CI: confidence interval, MetS: metabolic syndrome, Ref: reference.